Santen Pharmaceutical Co., Ltd. (SNPHY)
11.68
-0.58
(-4.73%)
USD |
OTCM |
Aug 27, 16:00
Santen Pharmaceutical Net Income (Quarterly) : 45.18M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.18M |
| March 31, 2026 | 99.13M |
| December 31, 2025 | 52.86M |
| September 30, 2025 | 54.20M |
| June 30, 2025 | 40.56M |
| March 31, 2025 | 55.75M |
| December 31, 2024 | 56.73M |
| September 30, 2024 | 54.26M |
| June 30, 2024 | 68.07M |
| March 31, 2024 | 0.8284M |
| December 31, 2023 | 49.36M |
| September 30, 2023 | 61.30M |
| June 30, 2023 | 75.68M |
| March 31, 2023 | 8.346M |
| December 31, 2022 | 41.91M |
| September 30, 2022 | -207.57M |
| June 30, 2022 | 51.54M |
| March 31, 2022 | 67.96M |
| December 31, 2021 | 44.31M |
| September 30, 2021 | 62.93M |
| June 30, 2021 | 67.31M |
| March 31, 2021 | -110.22M |
| December 31, 2020 | 69.34M |
| September 30, 2020 | 71.37M |
| June 30, 2020 | 56.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.18M |
| December 31, 2019 | 65.76M |
| September 30, 2019 | 62.78M |
| June 30, 2019 | 58.13M |
| March 31, 2019 | 77.86M |
| December 31, 2018 | 79.73M |
| September 30, 2018 | 67.50M |
| June 30, 2018 | 62.77M |
| March 31, 2018 | 73.07M |
| December 31, 2017 | 107.20M |
| September 30, 2017 | 56.17M |
| June 30, 2017 | 80.22M |
| March 31, 2017 | 40.16M |
| December 31, 2016 | 42.59M |
| September 30, 2016 | 50.63M |
| June 30, 2016 | 67.86M |
| March 31, 2016 | 30.27M |
| December 31, 2015 | 51.34M |
| September 30, 2015 | 296.87M |
| June 30, 2015 | 61.84M |
| March 31, 2015 | 53.54M |
| December 31, 2014 | 64.23M |
| September 30, 2014 | 54.04M |
| June 30, 2014 | 39.96M |
| March 31, 2014 | 16.93M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 710.72M |
| Daiichi Sankyo Co., Ltd. | 430.72M |
| Eisai Co., Ltd. | 120.18M |
| Chugai Pharmaceutical Co., Ltd. | 730.02M |
| Ono Pharmaceutical Co., Ltd. | 151.63M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 432.73M |
| Total Expenses (Quarterly) | 387.58M |
| EPS Diluted (Quarterly) | 0.1399 |
| Enterprise Value | 3.455B |
| Gross Profit Margin (Quarterly) | 54.66% |
| Profit Margin (Quarterly) | 10.44% |
| Earnings Yield | 6.57% |
| Operating Earnings Yield | 7.69% |